Bonk (SHOT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Safety Shot, Inc. entered into a definitive agreement to acquire all outstanding shares of Yerbaé Brands Corp. via a plan of arrangement, with closing targeted for Q2 2025, subject to shareholder, court, and regulatory approvals.
Yerbaé shareholders will receive 0.2918 shares of Safety Shot for each Yerbaé share, totaling 20 million Safety Shot shares, representing a $15.2M equity value and $19.7M enterprise value for Yerbaé.
The combined company aims to leverage operational synergies, expand distribution, and enhance product innovation in the wellness and functional beverage sector.
The transaction is expected to deliver significant cost savings, supply chain efficiencies, and access to new markets, with Yerbaé’s 2023 revenue at $12M.
Both boards unanimously approved the deal, supported by independent fairness opinions, and recommend shareholders vote in favor.
Voting matters and shareholder proposals
The transaction requires approval by at least two-thirds of Yerbaé shareholders and a majority of Safety Shot stockholders, as well as court and regulatory consents.
A joint proxy statement will be filed, and shareholders are urged to review all materials before voting.
Upon closing, Yerbaé shares will be delisted from the TSXV, and Yerbaé will apply to cease being a reporting issuer in Canada.
Board of directors and corporate governance
Yerbaé CEO Todd Gibson will join the Safety Shot board at closing and continue as Yerbaé’s CEO.
The combined company will be led by an experienced management team from both organizations.
Latest events from Bonk
- Amended registration for public stock offering, led by CEO Jarrett Boon, with $113K in expenses.SHOT
Registration Filing28 Jan 2026 - Patented dietary supplement business registers shares for resale, funding R&D and growth.SHOT
Registration Filing16 Dec 2025 - Registering 1.9M shares for resale; proceeds from warrants fund R&D and working capital.SHOT
Registration Filing16 Dec 2025 - Patented dietary supplement targets alcohol metabolism, with shares registered for resale on NASDAQ.SHOT
Registration Filing16 Dec 2025 - Registering 1.9M shares for resale, with proceeds from options and warrants funding R&D.SHOT
Registration Filing16 Dec 2025 - Registers 31.8M shares for resale after a strategic pivot to digital assets and DeFi.SHOT
Registration Filing10 Dec 2025 - Annual meeting to vote on director re-election, auditor ratification, and review key governance matters.SHOT
Proxy Filing2 Dec 2025 - Safety Shot will acquire Yerbaé, with shareholders exchanging shares at a 0.2918 ratio, pending approvals.SHOT
Proxy Filing2 Dec 2025 - Safety Shot and Yerbaé propose a merger, with Yerbaé shareholders to receive 0.2918 Safety Shot shares per share.SHOT
Proxy Filing2 Dec 2025